Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.697
https://www.valueinhealthjournal.com/article/S1098-3015(14)02627-8/fulltext
Title :
Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02627-8&doi=10.1016/j.jval.2014.08.697
First page :
A345
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
121